Statement from the Authors In preparing this document the Authors aimed to pool current information on canine and feline mast cell disease. The information was gathered from international studies and a emphasis was placed on material and opinion with a strong evidence base. We intend it to form the basis of our understanding in this disease at the current time and we anticipate that it will be particularly useful for the general practitioner. It should be emphasized that the authors are presenting this work from a European perspective.

This study evaluated efficacy and side effects of masitinib in canine epitheliotropic lymphoma. Complete remission occurred in 2 of 10 dogs and lasted for median 85 days. Five dogs went into partial remission for median 60.5 days. Three pretreated dogs did not respond to therapy. Side effects occurred in six dogs and were mostly mild to moderate. Immunohistochemistry was available for eight dogs. KIT receptor was negative in all of them, six of eight lymphomas stained strongly positive for stem cell factor (SCF). platelet-derived growth factor (PDGF)-AA was weakly positive in two and negative in six. PDGF-BB was negative in four tumours, weakly positive in one and strongly positive in three. One was strongly positive for PDGF receptor (PDGFR)-, seven were negative for that receptor. Five showed strong expression of PDGFR-, two showed weak expression, one was negative. In conclusion, masitinib is effective in treating canine epitheliotropic lymphoma. But its effects are most likely not generated through the KIT receptor.

For cats, appropriate housing conditions and a quick adjustment to new surroundings should be promoted during temporary stays in animal shelters and boarding catteries. In this study the development of stress in 140 boarding cats during a two-week stay under single-, pairand group-housing conditions in a boarding cattery was investigated and compared with the stress levels of 45 control cats which had been at the animal shelter for several weeks. Signs of stress were recorded by a non-invasive Cat-Stress-Score.Overall, the levels of stress in boarding cats declined during the two weeks of boarding, with a pronounced decline in the first days, but did not reach the stress levels of the control group by the end of the second week of housing. In the second week, the average stress level of about one third of all boarding cats was rated higher than ‘weakly tense’ with 4 per cent of cats rated even higher than ‘very tense’. Neither housing style (single, paired or grouped) nor age had an influence on stress levels.It was concluded that about two thirds of the boarding cats adjusted well to the boarding cattery during a two-week stay, while for the other third, temporary boarding was more stressful. For 4 per cent of the animals the two-week stay in a boarding cattery was classified as inappropriate because no reduction of their high stress levels occurred.

CV and ICV are rare disorders that seem to carry a better prognosis than mesenteric volvulus. Immediate laparotomy is recommended in suspected cases and the prognosis is fair.

The purpose of this study was to evaluate a possible association between mammary tumour size and increasing degree of malignancy. Data of 625 dogs with a total of 1459 mammary tumours were analysed retrospectively. 80.3% dogs were intact, mean age at diagnosis was 9.7 ± 2.5 years, 75.8% were pure breed dogs. Median body weight was 20.0 kg. Malignant tumours (n = 580) were significantly larger than their benign counterparts (1.94 cm vs 0.90 cm in mean, respectively; P ≤ .0001), resulting in a positive correlation between increasing tumour size and a change from benign to malignant (P ≤ .0001; r s = 0.214). When malignant tumours were grouped into four degrees of increasing malignancy (complex/simple/solid/anaplastic carcinomas) a significant positive correlation between increasing tumour size and more malignant tumour degree (P ≤ .0001; r s = 0.195) could be demonstrated. In a number of cases, highly malignant tumours were found to arise within less malignant lesions, supporting the concept of a further progression within the malignant tumour subtypes. In patients with multiple tumours, mean tumour sizes for malignant tumours were significantly smaller compared to patients with only one tumour (1.67 vs 2.71 cm in mean, respectively; P < .0001). These findings suggest that mammary tumours progress not only from benign to malignant but also from low to highly malignant. An increase in diameter of only a few millimetres may therefore have a big impact on the patient's outcome.